Related Experiment Videos
Late graft patency and symptom relief after aorta-coronary bypass
Insights
Coronary artery bypass grafting (CABG) demonstrated excellent long-term results. Most patients remained asymptomatic or improved, with high graft patency rates and overall survival exceeding 92% at four years.
Area of Science:
- Cardiovascular Surgery
- Cardiac Surgery Outcomes
- Graft Patency Rates
Background:
- Coronary artery bypass grafting (CABG) is a critical intervention for coronary artery disease.
- Early outcomes and long-term graft patency are key indicators of surgical success.
Purpose of the Study:
- To evaluate the early and long-term outcomes of coronary artery bypass grafting (CABG).
- To assess graft patency rates and patient survival following CABG surgery.
Main Methods:
- Retrospective analysis of 106 patients undergoing elective or emergency CABG.
- Perioperative assessment, including angiography at 1-2 weeks and 1-2 years post-surgery.
- Clinical follow-up at 1 year and 3-4 years to assess patient status and survival.
Main Results:
- Low operative mortality (3.8%) and early hospital death.
- High graft patency rates: 94% at 1-2 weeks and 94% at 1-2 years post-CABG.
- Excellent long-term patient outcomes: 99% asymptomatic/improved at 1 year and 93.9% at 3-4 years, with 92.4% overall survival at 4 years.
Conclusions:
- Coronary artery bypass grafting (CABG) provides durable and effective long-term relief for patients with coronary artery disease.
- Sustained graft patency and significant improvement in patient quality of life are hallmarks of successful CABG.
- CABG surgery is associated with favorable long-term survival rates.
Abstract:
One hundred six consecutive patients underwent elective or emergency coronary artery bypass grafting (CABG) between January, 1974, and November, 1975. There were 90 men of an average age of 54 years and 16 women an average of 64 years. Unstable angina (preinfarction angina, angina decubitus, and crescendo angina) was present in 54 patients of this group and eight were in congestive heart failure. Sixty-two of the 106 had previously had myocardial infarctions and four had evolving infarctions. There were four operative deaths (3.8%) and one early hospital death (less than 30 days' hospitalization). Perioperative infarction occurred in five of the survivors. Of the 197 grafts placed in the 101 survivors, 94% were patent by angiography at 1 to 2 weeks (175 of 187 vein grafts and 10 of 10 left internal mammary grafts). At 1 to 2 years after CABG, 62% of the survivors consented to repeat angiography at which time 94% of the grafts were patent (101 of 108 vein grafts and seven of seven left internal mammary grafts). Clinical follow-up of 81 of the 101 survivors at 1 year found 99% of them to be asymptomatic or improved. Repeat clinical follow-up of all survivors (99 of 101) at 3 to 4 years found 93.9% asymptomatic or improved. Overall survival, including operative deaths, was 92.4% at 4 years.